6Kollmannsberger C,Harmann JT,Kanz C.Risk of secondary'myeloid lelkemia and myelodysplastic syndrome foIlowing standard-dose chemotherapy or high dose chemotherapy with stem cell support in patients with potentially curable malignancyes.J-Cancer-Res-Clin-Onco1,1998,124(3-4):207.
7Laupt R,Fears TR,Helse A.Kisk of secondary lellkemia after treatment with etoposide for langerhans cell histocytosis inItaly and Austrian-German populations lnt-Caucer,1997,71(1):9.
8Chen CL,Fuscoe JC,Liu Q,et al.Relationship between cytotoxicity and site specific DNA recombination after in vitro exposure of leukemia cells to etoposide J-Natl-Cancer-lnst,1996,88(24):1840.
9Sandier ES,Friedman DJ,Mustafa MM,et al.Treatmeut of children with epipodophyllotoxin-induced secondary acute myeloid leukemia.Cancer,1997,79(5):1049.
10Anderson JE,Storb R,Appellbaum FR,et al.Stem cell transplantation for secondary acute myeloid leukemia:evaluation of transplantation as initial therapy or following induction chemotherapy blood,1997,89(7):2578.
